Showing results (171-180 of 1,898) with videos related to
Sort By:
Pageof 190
Current Neuropharmacology|December 7, 2018
Application of the Co-Agonist Concerted Transition Model to Analysis of GABAA Receptor PropertiesAllison L Germann, Joe Henry Steinbach, Gustav AkkCurrent Neuropharmacology|December 7, 2018
Neuroprotective Role of Hypothermia in Hypoxic-ischemic Brain Injury: Combined Therapies using EstrogenNicolás Toro-Urrego, Diego Julián Vesga-Jiménez, María Inés Herrera, et al.Current Neuropharmacology|November 28, 2018
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's DiseaseIván Carrera, Ramón CacabelosCurrent Neuropharmacology|August 28, 2020
Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery SystemsVimal Patel, Vishal Chavda, Jigar ShahCurrent Neuropharmacology|December 2, 2009
Monotherapy to polytherapy: antiepileptic drug conversions through the spectrum of epilepsy careErik K St LouisCurrent Neuropharmacology|December 2, 2009
Presynaptic cell dependent modulation of inhibition in cortical regionsAfia B AliCurrent Neuropharmacology|July 23, 2025
Exogenous Melatonin as a Sleep-promoting Agent beyond its Chronobiotic Properties: A Scoping Review of its Effects on Key Sleep-wake NeurotransmittersLetizia Biso, Nicola Luigi Bragazzi, Marco Bonaso, et al.Current Neuropharmacology|July 22, 2025
Proton-Sensitive Receptors/Channels: Therapeutic Target for Ischemic Stroke, Focusing on Their Roles and MechanismsYao Cheng, Yu-Jie Zhai, Shao-Shuai Wang, et al.Current Neuropharmacology|July 22, 2025
The Role of the Microbiota-Gut-Brain Axis in Perinatal Depression: Novel Insights for TreatmentJiajing Chao, Zhangmin Tan, Zhe Li, et al.Current Neuropharmacology|November 4, 2025
Low-dose Olanzapine and Sertraline Combination Therapy for Metabolic Disturbance in Patients with Schizophrenia: A Large-scale, Open-label Randomized TrialXiaoni Guan, Meihong Xiu, Fengchun WuPageof 190